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As with studies on the Na + / K + pump24, early results on 
Na+ /Ca2+ exchange appeared inconsistent with consecutive ion 
exchange models (see ref. 5 for review). Our work provides 
strong support for a consecutive Na+/Ca2+ exchange mechan-
ism and should facilitate structure-function studies ofthe cloned 
Na+ /Ca2+ exchanger. The results of both ion jump experiments 
and steady-state I ~aCa measurements are inconsistent with Ca2+ 
translocation involving net negative charge movement8 • We con-
clude from our site-density estimates and I NaCa measurements 
that maximum exchanger turnover rates are about 5,000 S-I . As 
already proposed for the Na + / K + pumpl 2-17 and rod out er 
segment Na + / Ca2+ , K + exchanger2,22, voltage-dependence must 
reside in the binding and release of extracellular Na+ or a closely 
associated occlusion/ deocclusion reaction. 0 
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THE al and a2 domains of major histocompatibility complex 
(MHC) class I molecules function in the binding and presentation 
of foreign peptides to the T-cell antigen receptor and control both 
negative and positive selection of the T-ce)) repertoire l - 3 , Although 
the a3 domain of class I is not involved in peptide binding, it does 
interact with the T-cell accessory molecule, CD8 (refs 4, 5). CD8 
is important in the selection of T cells as anti-CD8 antibody 
injected into perinatal mice interfers with this process6 • We pre-
viously used a hybrid class I molecule with the a 11 a2 domains 
from L d and the a3 domain from Q7b and showed that this molecule 
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binds an Ld-restricted peptide but does not interact with CD8-
dependent cytotoxic T lymphocytes7• Expression of this molecule 
in transgenic mice faUs to negatively select a subpopulation of 
anti-L d cytotoxic T Iymphocytes. In addition, positive selection of 
virus-specific L d -restricted cytotoxic T lymphocytes does not occur. 
We conclude that besides the a1la2 domains of class I, the a3 
domain plays an important part in both positive and negative 
selection of antigen-specific cells. 
To examine the role of the a3 domain of class I molecules 
in the responses of alloreactive and antigen-specific cytotoxic 
T Iymphocytes (CTL), we generated two transgenic mouse 
strains, C3H.Ld and C3H.LQ3, derived from C3H/ HeJ (H_2k ) 
mice. C3H.Ld express intact Ld , whereas C3H.LQ3 ex press an 
LU molecule whose a3 domain is switched with Q7 b . The Q7 b 
a 3 domain differs from LU at live residues and in addition has 
a unique three-amino-acid insert at positions 275-277 (ref. 8). 
We showed that this molecule (L Q3) binds the same viral peptide 
as Ld but is not recognized by peptide-specific CD8-dependent 
CTL (ref. 7). Similar observations have been reported with a 3 
mutant class I molecules not recognized by CD8-dependent 
CTL, the defect being due to an alteration in the binding site 
for CD8 (refs 4,5). 80th L d and L Q3 genes contain the same 
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FIG, 1 Cell-surface expression of endogenous or transgene cl ass I 
expression on spleen cells of C3H,L d (a-d) and C3H,L Q3 (e-h) transgenie 
mice was confirmed by fluorescent antibody staining and analysis on a 
FACScan flow cytometer (Becton Dickinson), Antibodies used in these 
analyses include: a and e, f luorescein isothiocyanate-goat anti-mouse IgG; 
b and f. 28-14-8 (anti-Ld ", 3 domain); c and g, 30-5-7 (anti-Ld ", 2 domain); 
d and h, 11-4-1 (anti-Kk) (American Type Culture Collection). C3H.Lo and 
C3H,L Q3 express comparable levels of L d or L Q3, respectively, A similar 
distribution of antigen is also observed in thymus (da ta not shown), 
METHOOS, C3H,L d and C3H,L Q3 mice were generated by injection of C3H/HeJ 
oocytes with either a 13.2-k ilobase (kb) Pvul / Sall fragment containing the 
27 ,5,27 L d geneS, or a 9,9-kb Sphl fragment of the L Q3 hybrid class I gene 
construct'. Each transgene includes the 5' upstream regulators and pro-
moters for wild-type L d, and expression is detected on lymphoid tissues as 
expected, Mice carrying the transgene were identified by dot-blot analysis 
using a pBR322 probe, 
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L d promoter, and antigen expression by these transgenic strains 
is similar (Fig. 1). 
We tested the ability of C3H spleen cells to respond to Ld or 
L Q3. C3H anti-C3H.Ld primary lymphocyte culture (MLC) 
effector cells recognize Ld but not LQ3, and this lysis is readily 
inhibited by anti-CD8, in agreement with our previous findings 7 
(Fig. 2a). When C3H.LQ3 spleen cells are used to stimulate a 
primary in vitra MLC, recognition of Ld does occur, and this 
response is also inhibited by anti-CD8 (Fig. 2b). Although no 
lysis is detected on L Q3 targets, in some experiments a low 
response is seen to L Q3 (data not shown). Thus, spleen cells 
from L Q3 mice do stimulate a primary in vitro anti-L d response. 
The ability of L Q3 transgenie cells to sensitize anti-L d CTL is 
probably due to the relatively high levels of this molecule on 
antigen-presenting dendritic cells9 • This would be consistent 
with the data of Alexander et al. \0, who show that antigen density 
affects the extent of CD8 dependency of T-cell recognition. 
Accordingly, the CTL generated should be biased towards more 
efficient recognition of L d versus L Q3 on L-cell targets that 
express relatively low levels of antigen, presumably because the 
molecule has a wild-type L d a 3 domain. 
Secondary C3H anti-Ld recognize Ld, and unlike primary 
cultures, these cells are relatively resistant to blocking by anti-
CD8 (ref. 7) (Fig. 2c). This is a characteristic ofmany secondary 
alloreactive CTLll ,12. LQ3 targets are also recognized by these 
effectors7, but are readily blocked by anti-CD8 (Fig. 2c). This 
finding is similar to that reported by Salter et al, 5, who noted 
that T-cell recognition of a3 mutant class I molecules is par-
ticularly sensitive to anti-CD8 blocking. Secondary C3H anti-
L Q3 CTL recognize both L d and L Q3 and these responses are 
resistant to blocking by anti-CD8 (Fig. 2d). Thus, stimulation 
with these molecules ilIuminates a hierarchy of CD8 depen-
dence, presumably reflecting differences in T cell-receptor 
affinities for antigen. Only relatively high-affinity anti-Ld CTL 
recognize L Q3 . 
As our data show that only relatively high-affinity CTL recogn-
ize L Q3, we investigated whether expression of the L Q3 molecule 
during T-cell development in C3H.L Q3 animals eliminates all 
Ld-reactive T cells from the repertoire. We therefore cultured 
L Q3 responder cells with L d stimulators and found that they do 
respond to L d, albeit weakly (Fig. 3a). Addition of supernatant 
containing interleukin-2 (IL-2) to this culture enhanced this 
response (Fig, 3e). We restimulated these cultures for two further 
weeks and found strong L Q3 anti-L d CTL activity (Fig. 3c). 
These CTL are very sensitive to anti-CD8. A dilution of anti-CD8 
monoclonal antibody, which fails to inhibit a CD8-dependent 
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FIG. 2 C3H.l d or C3H.l Q3 spleen cells stimulate anti-l d responses. a, C3H 
anti-C3H.l d or b, C3H anti-C3H.l Q3 primary in vitro MlC, d6 assay. c, 
Secondary C3H anti-C3H.l d, or d, C3H anti-C3H.l Q3 CTl generated from C3H 
mice that rejected ld or l Q3 skin grafts (about day 13), were immunized 
intraperitoneally with 50 x 106 C3H.l d or C3H.l Q3 spleen cells, respectively, 
after >3 weeks and restimulated in vitro on day 7 or 14 and assayed 6 
days later. Targets of a standard 6-h 5iCr release assay are l-cell transfec-
tants that express l d (a.), l Q3 (e), or control (.) untransfected cells 
(thymidine kinase, tk+), assayed in medium alone or l d (6) or l Q3 (0) in the 
presence of a 1 :20 dilution of culture supernatant of anti-CD8 monoclonal 
antibody YTS169.4 (YT) (ref. 21). l-cell targets were matched for roughly 
equivalent expression of transfected class I gene products 7 . 
primary anti-Ld response (Fig. 3f), completely blocks L Q3 anti-L d 
CTL, suggesting that receptors on these cells have a very 
low affinity for Ld (Fig. 3c). Culture of Ld responder cells with 
L Q3 for six days or for more than three weeks with additional 
stimulators plus IL-2 does not generate CTL activity, as we 
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FIG. 3 C3H.L Q3 responder cells recognize C3H.l d 
in a CD8-dependent manner. a, C3H.l Q3 anti-C3H.l d 
or b, C3H.l d anti-C3H.L Q3 primary in vitro MlC 
generated in the absence of exogenous Il-2, day-6 
assay. C, C3H.l Q3 anti-C3H.l d or d, C3H.l d anti-
CH3.L Q3 CTl lines generated from primary in vitro 
MlC and fed on days 7,14, and 21 with C3H.l d or 
C3H.l Q3 stimulator cells, respectively, and fresh 
medium plus Il-2 (ref. 22) and assayed on day 24. 
e, C3H.L Q3 anti-C3H.l d primary in vitra MlC gener-
ated in medium plus Il-2, day-6 assay. f, C3H 
anti-C3H.l d CTl line from primary in vitro MlC fed 
on days 7, 14 and 21 and assayed on day 24. 
Targets of a standard 6-h 5iCr release assay are 
l-cell transfectants that express l d Ca.), l Q3 (e), 
or untransfected control (tk +) (.), assayed in 
medium alone; of ld in the presence of a 1:40 
dilution of anti-CD8 culture supernatant C"», or l d 
in the presence of a 1: 500 dilution of control 
monoclonal anti-CD44 (+), which reacts with a 
molecule present on CTl, which is not involved in 
killing23 Similar results were seen using con-
canavalin A blast target cells (data not shownl. o~ • .--I=·- * 
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FIG. 4 C3H.L Q3 spleen cells do not respond to MCMV nonamer 
peptide (CMV-pep) presented by C3H.L Q3 or C3H.L d stimulator 
cells. a and b, C3H.L d anti-C3H.L d +CMV-pep or C and ci. 
C3H.L Q3 anti-C3H.L Q3 +CMV-pep or e and f, C3H.L Q3 anti-
C3H.L d +CMV-pep CTL were generated by primary in vitra 
MLC followed by two weekly passages with stimulator cells 
plus CMV-pep in IL-2-containing medium7 . In e and f, data 
represent two independent experiments. Target cells of a 
standard 6-h 51Cr release assay were control L cells ( x), or 
L cells that express Ld (6) or L Q3 (0) cultured in the presence 
(filled) or absence (open) of MCMV peptide (YPHFMPTNL; one-
letter amino-acid code) at 500,...,g ml-1 for 15 h at 37 °C14; 
or SV40-transformed BALB/c embryonic fibroblast cells (EF) 
untransfected (0) or transfected with the iel gene encoding 
the MCMV pp89 protein (.)24 
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expeeted (Fig. 3b, d). Thus, although expression of the LQ3 
moleeule eliminates high-affinity anti-self T eells, a population 
of low-afinity L d -reaetive T eells, revealed by their reaetivity on 
L d but not L Q3, evades this negative seleetion, 
As class I moleeules funetion in positive seleetion of the 
antigen-specifie repertoire2, we next examined the effeet of the 
Q7b a 3 domain on the generation of virus-specifie L d -restrieted 
T-eell responses. We used a synthetie peptide (designated CMV-
pep) derived from the immediate early protein ppS9 of murine 
eytomegalovirus (MCMV) whieh binds to both L d and L Q3 (see 
legend to Fig. 4)7,13,14. Primary Ld anti-Ld-CMV-pep CTL 
reeognize CMV-pep-pulsed L d target eells (Fig. 4a). This 
response is bloeked by anti-CDS and these CTL fail to reeognize 
peptide pulsed L Q3 targets (Fig. 4a and ref. 7). Hut no anti-CMV-
pep aetivity is deteeted from LQ3miee (Fig. 4e). Further, Ld_ 
CMV-pep, whieh expresses a native L d a3 domain and therefore 
might be reeognized by low-affinity L Q3 -restrieted anti-CMV-pep 
CTL, is not reeognized by L Q3 eells (Fig. 4e). 
We also tested CTL reaetivity with target eells that express 
equivalent levels of Ld, but whieh differ as to whether they 
express the MCMV ppS9 antigen. Ld anti-Ld-CMV-pep CTL 
reeognize L d + ppS9 eells, but not untransfeeted eells (Fig. 4b), 
indieating that reeognition of Ld-CMV-pep is not due to 
inereased expression of L d in CMV-pep-treated eells. L Q3 anti-
L Q3 -CMV-pep eultures do not generate anti-L dppS9 aetivity 
illustrating further the inability of these eells to stimulate L Q3_ 
restrieted antigen-specifie responses effeetively (Fig. 4d). 
As the presenee ofthe Ld a3 domain might allow low-affinity 
CTL to respond to CMV-pep, we eo-eultured L Q3 responders 
with Ld-CMV-pep antigen-presenting eells. These eultures do 
not generate L d -restrieted CMV-pep-specifie CTL (Fig. 4e, f). 
In some experiments we noted LQ3 anti-Ld alloreaetivity (Fig. 
4f), as already deseribed (Fig. 3a, e, e). But this alloreaetivity 
is redueed eompared with eultures in whieh peptide is omitted 
(eompare Figs 4f and 3e; also data not shown), presumably 
beeause CMV-pep pre-empts self peptides from gaining aeeess 
to L d, whieh eontributes to the bulk of alloreaetive specificities. 
This is in agreement with the finding that bin ding of specifie 
peptides to the L d moleeule influenees L d antigenie strueture l5 • 
Regardless of whether an anti-L d response was deteeted in these 
eultures, L Q3 anti-L d -CMV-pep did not elieit deteetable antigen-
specifie responses (Fig. 4e,j). 
Thus, stimulation of CTL preeursors with L d and L Q3 allows 
us to illustrate a hierarehy of CTL affinities and CDS interaetions 
in vitro, and use of trans genie miee demonstrates that a similar 
in vivo hierarehy of affinities, one of whieh determines the T-eell 
720 
repertoire, is also influeneed by the a 3 domain of class 1. 
Previous data indieate that the specifieity of the T eell reeeptor 
plays a major part in determining the T-eell repertoire3. The 
funetion of CDS has been addressed in peripheral T eells where 
its aeeessory and eo-reeeptor funetions have been demon-
strated I6•17• CDS partieipates in the generation ofthe repertoire 
beeause anti-CDS antibodies injeeted into perinatal mice pre-
vent seleetion of CDS+ T eells6 . Downregulation of CDS 
expression has also been noted in trans genie miee bearing anti-
self reeeptors l8 • Further, using a mutant mouse strain laeking 
eell-surfaee CDS expression, Fung-Leung et al. 19 have shown 
that CDS is neeessary for the development of funetional allo-
reaetive or antigen-specifie class I, but not class 11, MHC-
restrieted T eells. 
Our data indieate that the a3 domain of class I eontrols 
positive seleetion of the TCR repertoire. This suggests that 
although CDS-independent CTL with high-affinity reeeptors for 
antigen ean funetion in the periphery, their generation is depen-
dent on this eo-reeeptor during ontogeny. This requirement 
eould refleet the aetion of CDS as an aeeessory moleeule with 
low-density class I on thymie stromal eells where edueation 
oeeurs, but we favour CDS as a eo-reeeptor required for signal-
ling20• The finding that anti-L d alloreaetive T eells are not eom-
pletely eliminated in L Q3 animals eould refleet either the reten-
tion of low-affinity eells requiring CDS as an aeeessory moleeule, 
or a CDS-dependent eo-reeeptor signalling event required for 
effieient negative seleetion. 0 
Reeeived 26 March; aceepted 4 July 1991. 
1. Bjorl<man, P. J. et al. Nature 329, 506-518 (1987). 
2. Marusie-Galesie, 5., Stephany, D. A., Longo, D. L. & Kruisbeek, A. M. Nature 333, 180-183 (1988). 
3. Teh, H. S. et al. Nature 335, 229-233, (1988). 
4. Connolly, J. M., Potter, T. A., Wormstall, E. & Hansen, T. H. J exp. Med. 168, 325-341 (1988). 
5. Salter, R. et al. Nature 345, 41-46 (1990). 
6. Zuniga-Pflueker, J. C., Jones, L. A., Longo, D. L. & Kruisbeek, A. M. J exp. Med.171, 427-437 (1990). 
7. Aldrieh, C. J. et al. J Immun. 146, 3082-3090 (19911. 
8. Stroynowski, I. A. Rev. Immun. 8, 501-530 (1990). 
9. Sprent, J. & Sehaeffer, M. Immun. Rev. 117, 213-234 (1990). 
10. Alexander, M. A., Damico, C. A., Wieties, K. M., Hansen, T. H. & Connolly, 1. M. J. exp. Med. 173, 
849-858 (1991). 
11. MacDonald, H. R., Glasebrook, Ä. l., Bron, C., Kelso, Ä. & Cerottini, J.-C. Immun. Rev. 68, 89-115 
(1982). 
12. Budd, R. C., Cerettini, J. C. & MaeDonald, J. I. J Immun. 138, 1009-1013 (1987). 
13. Reddehase, M., Rothbard, J. B. & Koszinowski, U. H. Nature 337, 651-653 (1989). 
14. Lie, W. R. et al. Nature 344, 439-441 (1990). 
15. Lie, W. R. et al. J. exp. Med. 173, 449-459 (1991). 
16. Norment, A. M., Salter, R. D., Parham, P., Engelhard, V. H. & Littman, D. R. Nature 336, 79-81 (1988). 
17. Zamoyska, R. R. et al. Nature 342, 278-281 (1989). 
18. Teh, H. 5., Kishi, H., Seott, B. & von Boehmer, H. J exp. Med. 169, 795-806 (1989). 
19. Fung-Leung, W.-P. et al. Cell, 65, 443-449 (1991). 
20. Teh, H. S. et al. Nature 349, 241-243 (1990). 
NATURE . VOl 352 . 22 AUGUST 1991 
21. Qin, S" Cobbold, S" Benjamin, R. & Waldmann, H. J. exp. Med. 169, 779-794 (1989). 
22. Aldrich, C. J., Jenkins, R. N. & Rich, R. R. J. Immun. 136, 383-388 (1986). 
23. Trowbridge, I. S" Lesley, J., Schulte, R" Hyman, R. & Trotter,J.lmmunogenetics 15, 299-306 (1982). 
24. Koszinowski, U. H" Keil, G. M., Schwarz, H., Schickedanz, J. & Reddehase, M. J. J. exp. Med. 166, 
289-294 (19871. 
ACKNOWLEDGEMENTS. This wor!< was supported by an NIH grant U.F.). We thank M. Zuniga for the 
L d gene. G. D. Senn 111 for technical assistance, and B. Washington for secretarial help. 
Co-engagement of CDS with the 
T cell receptor is required for 
negative selection 
Amie L.lngold*, Carlisle Landelt, Cindy Knall*:j:, 
Gien A. Evanst & Terry A. Potter*:j: 
* Division of Basic Immunology, National Jewish Center for Immunology 
and Respiratory Medicine, Denver, Colorado 80206, USA 
:j: Department of Microbiology and Immunology, and the Cancer Center, 
University of Colorado Health Sciences Center, Denver, 
Colorado 80206, USA 
t The Molecular Genetics Laboratory, Salk Institute for Biological Studies, 
San Diego, California 92138-9216, USA 
ALTHOUGH it is established that the CD8 and CD4 co-receptors 
are involved in T-lymphocyte recognition and activation in the 
periphery, it is less clear whether these molecules participate in 
thymic selection events. Analysis of thymic selection in mice trans-
genic for T cell-receptor genes l --4 or for major histocompatibility 
complex (MHC) genesS, or mice injected with antibodies against 
CD8, CD4 or MHC mOlecules6-8, is consistent with the participa-
tion of CD8 and CD4 in thymic selection. But antibody-mediated 
crossIinking of surface receptors in thymic organ cuitures9 has 
indicated that CD8 is not involved in thymic deletion. We show 
here that mice transgenic for a mutant MHC class I molecule 
that cannot interact with CD8 do not delete CD8-dependent T 
cells reactive with the wild-type molecule. This finding unequivo-
cally establishes that for negative selection in the thymus, CD8 
must interact with the same MHC class I molecule as the T cell 
receptor. 
The role initially proposed for CD8 and CD4 was to bind to 
MHC dass I and dass 11 molecules, respectively, and so increase 
the avidity ofthe interaction between effectorTcells and antigen-
presenting cells 10,11. The association of the protein tyrosine 
kin ase p56\ck with CD8 and CD4 (refs 12-15) indicates that 
these coreceptors could also have a function in signal transduc-
tion. We have focused on the identification of the binding site 
for CD8 on MHC dass I molecules, and have shown that 
substitutions at amino-acid residue 227 (refs 16-18) and at other 
residues between 222 and 229 (ref. 19) of dass I molecules 
prevents this molecule from interacting with CD8. A similar 
result was obtained using a conjugate binding assalo. We con-
duded that for effector cell function of CD8-dependent cytotoxic 
T Iymphocytes (CTL), the T cell receptor (TCR) aß molecule 
and CD8 must interact with the same MHC dass I molecule. 
This finding is one of the criteria for distinguishing between the 
terms co-receptor and accessory molecule21 • 
To establish unequivocally a role for CD8 in thymic selection, 
we derived mice transgenic for a gene encoding the H-2Kb a1 
and a2 domains and the a3 domain from either the wild-type 
H-2Dd gene (this line is designated 28.1) or a mutant H-2Dd 
gene (this line is designated 29.7) which has a single amino-acid 
substitution at residue 227 (Glu ~ Lys) that destroys the interac-
tion with CD8 (ref. 18). The genes used to derive these mice 
were identical in the 5' and 3' flanking regions to the H_2Dd 
gene used to demonstrate that transgene-encoded dass I 
molecules function identically to endogenously encoded dass 
I molecules22,23. Our transgenic mice were originally derived on 
NA TURE . VOl 352 . 22 AUGUST 1991 
LETTERS TO NATURE 
a (C57B1/6 x BALB/c) F2 background and were backcrossed 
to B10.D2 for two generations to obtain H_2d homozygosity 
(confirmed by analysis using the polymerase chain reaction 
(PCR) and oligonudeotides specific for H_2b or H_2d dass 11 
genes). These mice expressed the product of the transgene on 
spleen cells at a level slightly above the expression of H_2Kb 
on spleen cells of H_2b / H_2d F1 mice (Fig. 1). Analysis by 
two-colour fluorescence activated cell sorting (FACS) of dass 
I expression on thymocytes established that cells expressing 
high levels of H-2d -encoded dass I molecules also expressed a 
high level of the transgene-encoded dass I molecule, and that 
the ratios of T: B cells and of CD4+: CD8+ T cells did not alter 
in the peripheral lymphoid organs of these mice (data not 
shown). To examine reactivity for H-2Kb in the absence of any 
other known MHC gene disparity, the transgenic mice were 
mated with B10.AKM (KkIkDq) and the response to B10.MBR 
(KbIkDq) was analysed. In vitro stimulation of spleen cells from 
(BlO.AKM x 29.7)F1 mice (transgenic for the mutant H_2K b 
gene) with irradiated BlO.MBR spleen cells elicited anti-H-2Kb 
CTL that were cytotoxic for EL4 (H_2b) cells (Fig. 2a). As these 
CTL also killed M12.C3 cells transfected with the H-
2K bala2/H-2Dd wild-type a3 gene (M12.28Kb; Fig. 2b), the 
determinants recognized by these CTL were present on both 
wild-type H-2Kb molecules and H_2Kb/H_2Dd exon-shuffied 
molecules. This CTL population was not cytotoxic for M12.C3 
transfectants expressing the H-2Kb molecule in association with 
the mutated H-2Dda3 domain (M12.29Kb; Fig. 2e). To confirm 
that mice transgenic for the gene with the mutant a3 domain 
(29.7) were not tolerant to H-2Kba1/a2 determinants expressed 
in association with a wild-type a3 domain from either H-2Dd 
or H_2Kb, spleen cells from the 29.7 mice were stimulated in 
vitro with spleen cells from the 28.1 mice (transgenic for the 
H-2K b al/a2 H_2Dd a3 wild-type gene). In this strain combina-
tion, the only difference in MHC genes is the substitution at 
residue 227 in the transgene of the responder. CTL generated 
under these conditions killed both EL4 and the M12.28Kb cells 
(Fig. 3a and b), establishing that the mutation in the a3 domain 
of the 29.7 mice resulted in the failure of these mice to delete 
T cells alloreactive to H-2Kb a1/a2 determinants expressed in 
association with a wild-type a3 domain from either H_2Dd or 
H-2Kb. These CTL were completely inhibited by antibody to 
CD8 and did not kill the M12.29Kb cells (Fig. 3e), suggesting 
that there were no autoreactive CD8-independent T cells present 
in the 29.7 mice. Co-culture ofspleen cells from the (B10.AKM x 
28.l)F1 mouse with B10.MBR spleen cells did not generate any 
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FIG. 1 Flow microfluorometric analysis of H-2Kb expression on spleen cells 
from a, C57BL1.6; b, Bl0.D2; C, (C57BL/6 x DBAI2)Fl; d. e, two of the H-2Kb 
transgenic lines. The background staining for each population is represented 
in the same panel. 
METHODS. Spleen cells (106 ) were incubated with biotinylated monocional 
antibody EH144 (anti-H-2Kb ) for 30 min on ice, washed twice and then 
incubated for a further 30 min with fluoroscein isothiocyanate-conjugated 
avidin. After staining, cells were washed and the fluorescence of 10,000 
viable cells was measured on an EPICS Profile analyser on a logarithmic scale, 
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